Sulfamethoxazole and Trimethoprim description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Sulfamethoxazole and Trimethoprim

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

SULFAMETHOXAZOLE AND TRIMETHOPRIM DESCRIPTION


Sulfamethoxazole and Trimethoprim



Sulfamethoxazole and Trimethoprim



Inactive ingredients:

CLINICAL PHARMACOLOGY


DOSAGE AND ADMINISTRATION



Geriatric Pharmacokinetics:


Microbiology


INDICATIONS AND USAGE

Aerobic gram-positive microorganisms:


Aerobic gram-negative microorganisms:










Other Organisms:


Susceptibility Testing Methods:

Dilution Techniques:


**

Quality Control

**
Diffusion Techniques:


**
**

Quality Control

**

INDICATIONS & USAGE


Urinary Tract Infections:


Acute Otitis Media:


Acute Exacerbations of Chronic Bronchitis in Adults:


Shigellosis:


Pneumocystis Carinii Pneumonia:


Traveler's Diarrhea in Adults:


SULFAMETHOXAZOLE AND TRIMETHOPRIM CONTRAINDICATIONS



WARNINGS

FATALITIES ASSOCIATED WITH THE ADMINISTRATION OF SULFONAMIDES, ALTHOUGH RARE, HAVE OCCURRED DUE TO SEVERE REACTIONS, INCLUDING STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, FULMINANT HEPATIC NECROSIS, AGRANULOCYTOSIS, APLASTIC ANEMIA AND OTHER BLOOD DYSCRASIAS.
SULFONAMIDES, INCLUDING SULFONAMIDE-CONTAINING PRODUCTS SUCH AS SULFAMETHOXAZOLE/TRIMETHOPRIM, SHOULD BE DISCONTINUED AT THE FIRST APPEARANCE OF SKIN RASH OR ANY SIGN OF ADVERSE REACTION.
PRECAUTIONS
Cough, shortness of breath, and pulmonary infiltrates are hypersensitivity reactions of the respiratory tract that have been reported in association with sulfonamide treatment.
Thrombocytopenia









PRECAUTIONS


General:

CLINICAL PHARMACOLOGYDOSAGE AND ADMINISTRATION





Use in the Treatment of and Prophylaxis for Pneumocystis Carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome (AIDS):
WARNINGS



INFORMATION FOR PATIENTS





LABORATORY TESTS



DRUG INTERACTIONS














DRUG & OR LABORATORY TEST INTERACTIONS




CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

Carcinogenesis:


Mutagenesis:


Impairment of Fertility:





Teratogenic Effects: Pregnancy Category C.






Nonteratogenic Effects:
CONTRAINDICATIONS

NURSING MOTHERS

CONTRAINDICATIONS

PEDIATRIC USE

INDICATIONS AND USAGECONTRAINDICATIONS

GERIATRIC USE


WARNINGSADVERSE REACTIONSDOSAGE AND ADMINISTRATION
CLINICAL PHARMACOLOGY: Geriatric Pharmacokinetics

SULFAMETHOXAZOLE AND TRIMETHOPRIM ADVERSE REACTIONS

FATALITIES ASSOCIATED WITH THE ADMINISTRATION OF SULFONAMIDES, ALTHOUGH RARE, HAVE OCCURRED DUE TO SEVERE REACTIONS, INCLUDING STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, FULMINANT HEPATIC NECROSIS, AGRANULOCYTOSIS, APLASTIC ANEMIA AND OTHER BLOOD DYSCRASIAS (seeWARNINGSsection).




PRECAUTIONS:Use in the Treatment of and Prophylaxis for Pneumocystis Carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome (AIDS)




WARNINGS

Postmarketing Experience




OVERDOSAGE

Acute:




Chronic:


DOSAGE & ADMINISTRATION

Not recommended for use in pediatric patients less than 2 months of age.

Urinary Tract Infections and Shigellosis in Adults and Pediatric Patients, and Acute Otitis Media in Children:

Adults:


Children:



For Patients with Impaired Renal Function:


Acute Exacerbations of Chronic Bronchitis in Adults:


Pneumocystis Carinii Pneumonia:

Treatment: Adults and Children:



Prophylaxis:

Adults:


Children:



Traveler's Diarrhea in Adults:


HOW SUPPLIED





STORAGE AND HANDLING




REFERENCES








PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION

















Sulfamethoxazole and Trimethoprim


Sulfamethoxazole and Trimethoprim

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL













Sulfamethoxazole and Trimethoprim

Sulfamethoxazole and Trimethoprim TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-012(NDC:0603-5781)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
SULFAMETHOXAZOLE sulfamethoxazole 800 mg
TRIMETHOPRIM Trimethoprim 160 mg

Inactive Ingredients

Ingredient Name Strength
STARCH, CORN
DOCUSATE SODIUM
MAGNESIUM STEARATE
povidone
SODIUM BENZOATE
SODIUM STARCH GLYCOLATE TYPE A POTATO

Product Characteristics

Color Size Imprint Code Shape
white 19 mm 5898;V OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-012-03 20 in 1 BLISTER PACK
2 NDC:24236-012-04 14 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078060 2011-12-14


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.